← Leaderboards
Volkhard Lindner
Medical College Of Wisconsin
$9,438,796
Attributed
$11,384,190
Total exposure
19
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,384,190 · 19
By mechanism
R01$7,369,787 · 3
P20$3,403,953 · 15
P30$610,450 · 1
Top collaborators
- Joy Lincoln4 shared
- Sergey Ryzhov4 shared
Most similar at Medical College Of Wisconsin
Same institution · by research overlap
- David C. Warltier$6,944,044
- Garrett John Gross$6,798,110
- William M Chilian$13,254,233
- Joy Lincoln$8,281,958
- Martin Bienengraeber$1,114,342
Others in their field
Top investigators on “Tissues”
- David Heimbrook · Leidos Biomedical Research, Inc.$346,311,904
- Lawrence Corey · Fred Hutchinson Cancer Center$230,011,824
- Larry Arthur$159,140,370
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Judith S. Currier · University Of California Los Angeles$138,805,403
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$138,805,403
Research focus
TissuesFundingCellsResearch PersonnelBlood VesselsResourcesCenters Of Research ExcellenceMouse ModelAntibodiesImmunohistochemistryProductionTissue ProcessingPlastic EmbeddingHistopathologyServicesProteinsSourceTransgenic MiceGene TargetingStem CellsPhenotypeLaboratoriesRepairedIn Vivo
Grant awards (48)
Delineating the mechanisms underlying heart valve endothelial repair$405,392
R01 · FY2025 · HL
Histopathology and Microscopy Core$274,845
P20 · FY2025 · GM · contact PI
Delineating the mechanisms underlying heart valve endothelial repair$402,885
R01 · FY2024 · HL
Histopathology and Microscopy Core$275,570
P20 · FY2024 · GM · contact PI
Effect of CTHRC1 on endothelial cell survival after acute ischemia$534,576
R01 · FY2023 · HL · contact PI
Delineating the mechanisms underlying heart valve endothelial repair$493,529
R01 · FY2023 · HL
Histopathology and Microscopy Core$310,935
P20 · FY2023 · GM · contact PI
Effect of CTHRC1 on endothelial cell survival after acute ischemia$534,576
R01 · FY2022 · HL · contact PI
Delineating the mechanisms underlying heart valve endothelial repair$450,678
R01 · FY2022 · HL
Effect of CTHRC1 on endothelial cell survival after acute ischemia$534,576
R01 · FY2021 · HL · contact PI
Core C: Histopathology and Histomorphometry Core$169,007
P20 · FY2021 · GM · contact PI
Effect of CTHRC1 on endothelial cell survival after acute ischemia$534,576
R01 · FY2020 · HL · contact PI
Core C: Histopathology and Histomorphometry Core$154,671
P20 · FY2020 · GM · contact PI
Core C: Histopathology and Histomorphometry Core$148,939
P20 · FY2019 · GM · contact PI
Core C: Histopathology and Histomorphometry Core$147,366
P20 · FY2018 · GM · contact PI
Core C: Histopathology and Histomorphometry Core$167,609
P20 · FY2017 · GM · contact PI
Histopathology Core$121,351
P30 · FY2017 · GM · contact PI
Histopathology Core$121,773
P30 · FY2016 · GM · contact PI
Histopathology Core$122,141
P30 · FY2015 · GM · contact PI
Histopathology Core$122,460
P30 · FY2014 · GM · contact PI
Cthrc1 function as a novel TGF-beta antagonist in the vasculature$387,408
R01 · FY2013 · HL · contact PI
Histopathology Core$122,725
P30 · FY2013 · GM · contact PI
Cthrc1 function as a novel TGF-beta antagonist in the vasculature$372,488
R01 · FY2012 · HL · contact PI
Cthrc1 function as a novel TGF-beta antagonist in the vasculature$71,525
R01 · FY2012 · HL · contact PI
Cthrc1 function as a novel TGF-beta antagonist in the vasculature$376,250
R01 · FY2011 · HL · contact PI
CORE C: HISTOPATHOLOGY CORE$109,585
P20 · FY2011 · RR · contact PI
Cthrc1 function as a novel TGF-beta antagonist in the vasculature$376,250
R01 · FY2010 · HL · contact PI
CORE C: HISTOPATHOLOGY CORE$105,645
P20 · FY2010 · RR · contact PI
Cthrc1 function as a novel TGF-beta antagonist in the vasculature$376,250
R01 · FY2009 · HL · contact PI
CONTROL OF VASCULAR FIBROSIS AND COLLAGEN DEPOSITION BY NOVEL REGULATOR, CTHRC-1$188,035
P20 · FY2009 · RR · contact PI
CORE C: HISTOPATHOLOGY CORE$102,924
P20 · FY2009 · RR · contact PI
CONTROL OF VASCULAR FIBROSIS AND COLLAGEN DEPOSITION BY NOVEL REGULATOR, CTHRC-1$188,661
P20 · FY2008 · RR · contact PI
CORE C: HISTOPATHOLOGY CORE$110,640
P20 · FY2008 · RR · contact PI
CONTROL OF VASCULAR FIBROSIS AND COLLAGEN DEPOSITION BY NOVEL REGULATOR, CTHRC-1$188,078
P20 · FY2007 · RR · contact PI
CORE C: HISTOPATHOLOGY CORE$130,220
P20 · FY2007 · RR · contact PI
Remodelin, a Novel Vascular Injury and Bone Related Gene$298,028
R01 · FY2006 · HL · contact PI
CONTROL OF VASCULAR FIBROSIS AND COLLAGEN DEPOSITION BY NOVEL REGULATOR, CRHRC-1$192,145
P20 · FY2006 · RR · contact PI
CORE C: HISTOPATHOLOGY CORE$159,594
P20 · FY2006 · RR · contact PI
Remodelin, a Novel Vascular Injury and Bone Related Gene$305,200
R01 · FY2005 · HL
COBRE: MAINE MED CTR: CORE C: PATHOLOGY CORE$194,249
P20 · FY2005 · RR
Remodelin, a Novel Vascular Injury and Bone Related Gene$305,200
R01 · FY2004 · HL
CORE--PATHOLOGY$85,235
P20 · FY2004 · RR
Remodelin, a Novel Vascular Injury and Bone Related Gene$305,200
R01 · FY2003 · HL
Remodelin, a Novel Vascular Injury and Bone Related Gene$305,200
R01 · FY2002 · HL
Covalent FGF-2 Complexes in Angiogenesis$0
P20 · FY2002 · RR
Covalent FGF-2 Complexes in Angiogenesis$0
P20 · FY2002 · RR
Covalent FGF-2 Complexes in Angiogenesis$0
P20 · FY2001 · RR
Covalent FGF-2 Complexes in Angiogenesis$0
P20 · FY2000 · RR